MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

0.420 (0.0%)
2

T-O (am): 0.000 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score

MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS
Adj.
[M]
NP [M]
(adj)
NPM
(adj)
EPS
(adj)
E. QoQ
(adj)
E. YoY
(adj)
TTM EPS
(adj)
28 Feb 24 31 Dec 23 Other 31 Dec 23 2.24 -7.46 -6.07 -271.3% 0.00 -4.42 1.3% 36.1% 319.0% 392.1%
28 Nov 23 30 Sep 23 Other 31 Dec 23 2.27 -1.49 -1.45 -63.9% 0.00 -1.07 1.6% 40.6% 86.9% 271.0%
28 Aug 23 Q4 Jun 23 4 30 Jun 23 2.23 -9.98 -11.03 -494.9% 0.00 -8.47 227.8% 64.8% 285.4% 376.1%
23 May 23 Q3 Mar 23 3 30 Jun 23 0.68 -3.18 -2.86 -420.9% 0.00 -2.20 58.6% 86.6% 132.1% 245.7%
24 Feb 23 Q2 Dec 22 2 30 Jun 23 1.64 -1.27 -1.23 -75.0% 0.00 -0.98 56.9% 78.5% 245.6% 222.0%
23 Nov 22 Q1 Sep 22 1 30 Jun 23 3.81 0.85 0.85 22.2% 0.00 0.68 39.8% 59.1% 78.8% 254.4%
30 Aug 22 Q4 Jun 22 4 30 Jun 22 6.33 2.97 4.00 63.1% 0.00 3.25 24.6% 9278.3% 103.5% 289.7%
23 May 22 Q3 Mar 22 3 30 Jun 22 5.08 1.96 1.96 38.6% 0.00 1.60 33.4% 212.2% 94.3% 882.0%
16 Feb 22 Q2 Dec 21 2 30 Jun 22 7.63 1.01 1.01 13.2% 0.00 0.83 18.1% 5508.8% 323.0% 165.1%
30 Nov 21 Q1 Sep 21 1 30 Jun 22 9.32 0.24 0.24 2.6% 0.00 0.20 13601.5% 10608.0% 111.3% 128.7%
23 Sep 21 Q4 Jun 21 4 30 Jun 21 -0.07 -2.11 -2.11 3052.2% 0.00 -1.94 104.2% 2400.0% 1153.0% 61.3%
27 May 21 Q3 Mar 21 3 30 Jun 21 1.63 0.20 0.20 12.3% 0.00 0.19 1097.1% 428.6% 112.9% 112.0%
18 Feb 21 Q2 Dec 20 2 30 Jun 21 0.14 -1.55 -1.55 -1142.7% 0.00 -1.50 56.3% 97.3% 86.5% 106.4%
30 Nov 20 Q1 Sep 20 1 30 Jun 21 0.09 -0.83 -0.83 -957.5% 0.00 -0.80 2800.0% 98.9% 84.7% 2424.2%
21 Aug 20 Q4 Jun 20 4 30 Jun 20 0.00 -2.61 -5.44 -181200.0% 0.00 -5.25 99.0% 100.0% 226.9% 304.8%
22 May 20 Q3 Mar 20 3 30 Jun 20 0.31 -1.66 -1.66 -539.9% 0.00 -1.61 93.8% 95.3% 106.9% 73.6%
18 Feb 20 Q2 Dec 19 2 30 Jun 20 4.96 24.71 24.23 488.6% 0.00 23.41 36.8% 28.4% 73530.3% 2545.2%
19 Nov 19 Q1 Sep 19 1 30 Jun 20 7.85 0.10 -0.03 -0.4% 0.00 -0.03 11.8% 24.4% 97.5% 97.7%
27 Aug 19 Q4 Jun 19 4 30 Jun 19 7.02 -1.30 -1.34 -19.1% 0.00 -1.30 6.2% 7.0% 40.2% 7.8%
24 May 19 Q3 Mar 19 3 30 Jun 19 6.61 -0.93 -0.96 -14.5% 0.00 -0.93 4.6% 4.3% 3.3% 18.6%
22 Feb 19 Q2 Dec 18 2 30 Jun 19 6.93 -0.91 -0.99 -14.3% 0.00 -0.96 9.9% 8.5% 31.9% 20.4%
24 Aug 18 Q4 Jun 18 4 30 Jun 18 6.31 -1.54 -1.46 -23.1% 0.00 -1.40 3.8% 116.6% 0.1% 534.3%
24 May 18 Q3 Mar 18 3 30 Jun 18 6.56 -1.35 -1.46 -22.2% 0.00 -1.41 5.0% 303.1% 80.3% 1301.0%
26 Feb 18 Q2 Dec 17 2 30 Jun 18 6.91 -0.69 -0.81 -11.7% 0.00 -0.78 8.2% 237.6% 1.8% 71.5%
22 Nov 17 Q1 Sep 17 1 30 Jun 18 6.38 -0.79 -0.82 -12.9% 0.00 -0.80 119.2% 94.2% 345.7% 199.3%
30 Aug 17 Q4 Jun 17 4 30 Jun 17 2.91 0.39 0.34 11.5% 0.00 0.32 79.0% 57.3% 422.1% 193.9%
11 May 17 Q3 Mar 17 3 30 Jun 17 1.63 -0.09 -0.10 -6.4% 0.00 -0.10 20.5% 9.0% 77.9% 145.6%
21 Feb 17 Q2 Dec 16 2 30 Jun 17 2.05 -0.46 -0.47 -23.0% 0.00 -0.46 37.8% 35.9% 156.8% 196.3%
21 Nov 16 Q1 Sep 16 1 30 Jun 17 3.29 0.83 0.83 25.2% 0.00 0.88 77.6% 8.7% 627.2% 8.5%
30 Aug 16 Q4 Jun 16 4 30 Jun 16 1.85 0.12 0.11 6.2% 0.00 0.12 3.5% 44.8% 50.0% 76.1%
25 May 16 Q3 Mar 16 3 30 Jun 16 1.79 0.23 0.23 12.8% 0.00 0.24 44.0% 58.4% 53.4% 82.4%
24 Feb 16 Q2 Dec 15 2 30 Jun 16 3.19 0.49 0.49 15.3% 0.00 0.52 11.2% 13.5% 46.0% 63.9%
23 Nov 15 Q1 Sep 15 1 30 Jun 16 3.60 0.91 0.91 25.2% 0.00 0.96 7.3% 40.8% 89.9% 82.3%
24 Aug 15 Q4 Jun 15 4 30 Jun 15 3.35 0.48 0.48 14.2% 0.00 0.51 21.9% 67.8% 63.2% 103.8%
25 May 15 Q3 Mar 15 3 30 Jun 15 4.29 1.30 1.30 30.2% 0.00 1.38 16.2% 914.9% 4.2% 166.1%
13 Feb 15 31/12/14 2 30/06/15 3.69 1.35 1.35 36.6% 0.00 1.44 44.4% 167.0% 172.2% 261.3%

Historical Dividends

Financial Ratios

EPS -15.6 sen
Trailing PE (Sector Median: 22.5) 0.0
PEG 0.0
Altman Z -3.8
Beaver -6.886
Current Ratio 8.05
Debt-Equity (DE) Ratio 0.16
FCF Yield -44.13 %
Revenue QoQ -1.28 %
Revenue YoY 36.09%
Profit QoQ -318.99 %
Profit YoY -392.05 %
Profit Margin (Sector Median: 1.0) -288.91 %
ROE (ROIC: -96.86) -96.86 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 22.5)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 1.0)
ROE (ROIC: -96.86)
Altman Z

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 1 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.16
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] -6.07
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0.0
Expected Revenue (M) 0.0
Expected Growth (%) 0.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 2370000.0 units announced on 08 Aug 2022 at ~RM0.73

ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 13 Jul 2022 at ~RM0.955

ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 12 Jul 2022 at ~RM0.945

ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 120000.0 units announced on 08 Jun 2022 at ~RM0.63

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 694000.0 units announced on 16 Jul 2021 at ~RM1.56

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 851679.0 units announced on 24 Feb 2021 at ~RM1.19

TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 10 Feb 2021 at ~RM0.88

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 354070.0 units announced on 07 Jan 2021 at ~RM1.05

TAN SRI DATUK DR RAFIAH BINTI SALIM added 20000.0 units announced on 24 Dec 2020 at ~RM0.885

TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 22 Dec 2020 at ~RM0.83

TAN SRI DATUK DR RAFIAH BINTI SALIM added 60000.0 units announced on 16 Dec 2020 at ~RM0.78

Summary


Market Cap: 57 M.

Number of Shares: 137 M.

Adjusted Float: 87.3%.

Stock highly correlated with

MUDA (96%)

BESHOM (95%)

SKPRES (95%)

CLASSITA (94%)

MGRC provides genome sequencing and analysis services. Our services and pipelines are designed to rapidly sequence and analyse large volumes of genetic data and extract meaningful biological information for downstream research and development. The key components of our commercial operations are our Contract Genomics Services, Sequencing Services, and Data and Access Services. Our services and applications have been used extensively in significant projects, including the mapping of the lung cancer genome, and the sequencing and assembly of the oil palm genome. To date, the company have undertaken projects for large agriculture-based companies, major medical research institutions, and government linked or funded entities in Malaysia and abroad, including United States and Australia. Currently, MGRC are the only player in Malaysia providing commercial bioinformatics analysis services for data from multiple second and third generation sequencing machines, serving public and private sector organizations in Malaysia and internationally. They have established themselves as Malaysia's leading provider of Contract Genomics Services

Sectors: Healthcare, Health Care Equipment & Services, Penny Stocks

Share Registrar: SYMPHONY CORPORATE SERVICES SDN BHD

Code: 0155

Website: http://www.mgrc.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 30-Sep-2022

Shareholder % Value (M)
Rinani Group Berhad 11.21% 6.46
Pixelvest Sdn Bhd 7.54% 4.35
Bintai Trading Sdn Bhd 5.55% 3.2
Dynamic Prestige Consultancy Sdn Bhd 4.43% 2.55
Proven Venture Capital Plt 4.42% 2.55
Magnalogic Sdn Bhd 4.35% 2.51
Lim Wai Yee 3.38% 1.95
Munirah binti Haji Abdul Hamid 1.77% 1.02
Keh Chuan Choon 1.62% 0.93
Ong Tzu Chuen 1.57% 0.9
Mohd Rafael bin Mohd Shamsudin 1.56% 0.9
Yeo Tsu Sin 1.47% 0.85
Raja Abdullah Bin Raja Baharudin 1.39% 0.8
Tan Kok Aun 1.23% 0.71
Shia Xze Chyien 1.09% 0.63
Chng Teong Seng 1.08% 0.62
Shia Chee Fong 0.98% 0.56
Inertia AIF Sdn Bhd 0.95% 0.55
Noraziah binti Adnan 0.95% 0.55
Foo Chai Lee 0.92% 0.53
Khoo Hai Chew 0.82% 0.47
Shahril bin Shamsuddin 0.81% 0.47
Lee Chooi Bit 0.78% 0.45
Nor Azah binti Adnan 0.7% 0.4
Ng Soon Leong 0.7% 0.4
Cheong Kai Meng 0.66% 0.38
Keh Chuan Seng 0.64% 0.37
Lee Boon Sze 0.64% 0.37
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.